Wellington-based med-tech Volpara Health Technologies says has entered an agreement to buy 100 per cent of US company MRS Systems for US$14.6 million ($22m). Read full article. Volpara Health Technologies (ASX VHT) adoption of the SaaS business model was announced in its recent AGM presentation. Imaging Associates - Mitcham Private Hospital. The Company is engaged in developing digital health solutions to enable personalized breast cancer screening based on objective measurements of breast density, compression, and radiation dose. Volpara Acquires Breast Cancer Risk Assessment Company CRA Health, LLC. "Volpara partners with radiologists to give women the most accurate information possible regarding their breast health. MRS provides mammography reporting systems to over 1,600 hospitals and clinics. Press Release – Volpara Health Technologies. VHT headquarters (R&D and engineering) were established by Dr Highnam in Wellington, New Zealand. The remaining cash is to be invested ba… Volpara Health Technologies Limited is a leading provider of breast imaging analytics and analysis products that improve clinical decision-making and the early detection of breast cancer. NZ Tech Company Volpara Health Expands Further Into U.S. Tuesday, 2 February 2021, 10:57 am Press Release: Volpara Health Technologies. Volpara Health is our wholly owned sales and marketing subsidiary. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. SA), MIA Monash Radiology (Melbourne, VIC), Imaging Associates - Mitcham Private Hospital (Melbourne, VIC), Imaging Associates Radiology (Wagga Wagga, NSW), Sydney Breast Clinic (NSW), Women’s & Breast Imaging (Perth) and Wesley Breast Clinic (Auchenflower, QLD). However, that kind of increase in revenue is expected as it comes from a low base. © 2021 Volpara Solutions Limited. Get detailed information about the dividend date and dividend announcements for Volpara Health Tech. Volpara Health Technologies Limited (VHT) Overview. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support Volpara Health Technologies Limited VHT Add to Portfolio. Maecenas ut … Volpara Solutions news stories. Find the latest VOLPARA HEALTH TECHNOLOGIES LTD (VPAHF) stock quote, history, news and other vital information to help you with your stock trading and investing. The first Australian users of Volpara products include Dr Jones & Partners Medical Imaging (Adelaide, SA), Flinders Medical Centre (Adelaide, SA), Lyell McEwan Hospital (Elizabeth Vale. Wellington-based Volpara Health, has hit 2021 running with the acquisition of a breast cancer risk assessment company in Boston, CRA Health. Volpara Health Technologies Limited (VHT) is a MedTech SaaS company and is a provider … Volpara Health and DetectED-X Team Up to Improve Breast Density Assessment Nov 16, 2020 Volpara -- A New Zealand Health Tech Company -- Hires Katherine Singson As Silicon Valley-Based CEO Level 14, Simpl House, 40 Mercer Street, Wellington Central,Wellington, 6011, New Zealand, Volpara Health TechnologiesLevel 14, Simpl House, 40 Mercer Street, Wellington Central,Wellington, 6011, New Zealand, JFDCPA AdvisersSuite #9, Level 1, 357 Military RoadMosman, NSW 2088, Australia. In morning trade, the health … Rewards. 0.02 |-1.52 % As of 03/03/2021 05:35 PM (20 min delay) Open Price $1.315: Day Range 1.285-1.33: 52-Week Range 1.72-0.79: Market Cap $326 M: Prev Close $1.30: Today's Volume 517,423: Volume - 30 Day Avg 503,946: Total Shares Quoted VPAHF | Complete Volpara Health Technologies Ltd. stock news by MarketWatch. Find out more at Intelligent Investor In June 2019, Volpara acquired Seattle-based MRS Systems for NZ$23 million. In addition, our products hold CE Marking under European Medical Device Directive 93/42/EEC. The stock has a market cap of $290.02 million and a PE ratio of -31.67. The acquisition was financed via a capital raising, which saw Volpara raise NZ$58 million. View real-time stock prices and stock quotes for a full financial overview. Last updated Friday February 26th 1:35pm Risk Analysis. Breast-density detection tech company Volpara has acquired US company CRA Health in a deal which pushed its shares up more than 3 per cent. Volpara Health Tech markets two types of products in the Medical Equipment & Supplies industry. Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device and practice management software industry. Volpara users in Auckland, New Zealand are the breast imaging pioneers Auckland Breast Centre and St Marks Breast Centre. © 2021 Volpara Solutions Limited. Investor information about Volpara Health Technologies (ASX: VHT), developers of digital health services to enable personalised, high quality breast cancer screening based on objective measurements of breast density, compression and radiation dose. Volpara Health Technologies Limited is a research, development, and manufacturing company based in Wellington, New Zealand. Gain a trading edge with the auto pattern recognition feature and gain an insight into what the patterns mean. Volpara Health Technologies Limited holds certification to ISO27001 and ISO13485 and MDSAP 690110 certification for Japan, Australia, Canada, and the United States; and is a US FDA–registered establishment whose products are listed accordingly. Wellington-based Volpara Health… Revenue is forecast to grow 38.91% per year. Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, pricing and company announcements to find out. Xem thêm thông tin chi tiết về Cổ Phiếu Volpara Health Tech (VHT) bao gồm Giá Cả, Biểu Đồ, Phân Tích Kỹ Thuật, dữ liệu Lịch Sử, các Báo Cáo Volpara Health Tech và hơn thế nữa. The Volpara Health Technologies Ltd (ASX: VHT) share price has returned from its trading halt and is pushing higher on Tuesday. Is Volpara Health Technologies (ASX:VHT) a buy? All Rights Reserved. The stock had previously closed at A$1.35 ($0.92). Wellington tech company Volpara Health expands in USA. Vote “Outperform” if you believe VHT will outperform the S&P 500 over the long term. At that level they are trading at 39.46% discount to the analyst consensus target price of 0.00. With a diverse research team led by internationally recognized experts in medical physics, as well as proprietary medical imaging technology covered by multiple patents and trademarks, we apply science to the solving of clinical problems around the world. Volpara Health Technologies Limited is a New Zealand-based research, development, and manufacturing company that provides breast imaging analytics and analysis products. The Volpara Health Tech stock patterns are available in a variety of time frames for both long and short term investments. Volpara Health Tech (ASX:VHT) fell 1.5% on Tuesday . Last price $ 1.30. Analysts covering Volpara Health Technologies currently have a consensus Earnings Per Share (EPS) forecast of … VOLPARA HEALTH TECH : RESEARCH TIP UPDATES - FEBRUARY 2021 04 Feb, 2021. Read detailed company information including current share prices, financial summary, directors, announcements, dividends & news. Every day, Volpara software helps clinicians better understand their patients and administrators better understand their practices. Volpara -- A New Zealand Health Tech Company -- Hires Katherine Singson As Silicon Valley-Based CEO Experienced Strategist to Accelerate Adoption of Groundbreaking Breast Health Platform To reduce the mortality and cost of breast cancer by providing clinically validated software that underpins personalized, high-quality breast cancer screening. Volpara Health, which is listed on the ASX, is a health technology software company whose integrated breast care platform assists in the delivery of personalised patient care. Volpara Health Technologies (ASX: VHT) is a digital health company focused on early detection of breast cancer by improving the quality of screening using artificial intelligence (AI). The SaaS model has seen revenue increase at an astonishing rate of 1,945%. Volpara -- A New Zealand Health Tech Company -- Hires Katherine Singson As Silicon Valley-Based CEO. VHT was founded in 2009 by four of the world’s leading breast imaging experts: Professor Sir John Michael Brady and Dr Ralph Highnam from the University of Oxford, Professor Nico Karssemeijer from the University of Nijmegen and Professor Martin Yaffe from the University of Toronto. The company traded as low as A$1.32 ($0.90) and last traded at A$1.33 ($0.91), 434,964 shares traded hands during mid-day trading. With a diverse research team led by internationally recognized experts in medical physics, as well as proprietary medical imaging technology covered by multiple patents and trademarks, we apply science to the solving of clinical problems around the world. NZ Tech Company Volpara Health Expands Further Into U.S. February 2, 2021 PressRelease. All Rights Reserved. More Details. NZ Tech Company Volpara Health Expands Further Into U.S. Wellington-based Volpara Health, has hit 2021 running with the acquisition of a breast cancer risk assessment company in Boston, CRA Health. Tech & Telecom Share News ... On Monday, medical technology company Volpara Health Technologies Ltd completed an institutional placement raising $15 million at 60 cents per share. Volpara Health Technologies Limited is a research, development, and manufacturing company based in Wellington, New Zealand. Volpara Health Technologies (VHT) is forking out over $23 million to buy Boston-based breast cancer risk assessment company CRA Health; The buyout gives Volpara access to CRA's cloud-based breast cancer assessment software, which is highly complementary to Volpara's imaging and analytics tech The latest earnings, revenues and financial reports for Volpara Health Tech (VHT). Standard Product is lot simpler than Custom Product, so Volpara Health Tech produces Standard product in large batch sizes compare to Custom product which is produced in smaller batch sizes. This acquisition gives Volpara much stronger US exposure, experienced local headquarters, and accelerated sales through cross selling. The breast cancer tech specialist, ... Morgans analysts believe the 2020 guidance is conservative and "readily achievable", calling Volpara a key pick in the emerging health space. The stock […] Sign up for our VHT investor newsletters here. For sake of simplicity let us call them Healthcare Standard product and Healthcare Custom Product. Volpara Health Technologies Limited (VHT.AX) has received 52.63% “outperform” votes from our community. MarketBeat's community ratings are surveys of what our community members think about Volpara Health Technologies Limited (VHT.AX) and other stocks. Day Change. Shares in Volpara Health Technologies are currently priced at A$1.26. February 2, 2021 Business, Health, Latest Headlines, PressRelease. News from Volpara Health Technologies Wellington-based Volpara Health has hit 2021 running with the acquisition of a breast cancer risk assessment company in Boston, CRA Health.